Compare International Business Machines Corp (IBM) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
International Business Machines Corp vs ImmunityBio Inc. Common Stock — how do they compare? International Business Machines Corp trades at $226.5 (market cap $207.75B), while ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B). The key difference: International Business Machines Corp is far larger — about 20.1× ImmunityBio Inc. Common Stock's market cap, and International Business Machines Corp pays a 3.07% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold International Business Machines Corp for 88 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| IBM | IBRX | |
|---|---|---|
Market Cap | $207.75B | $10.33B |
Volume | 3,864,661 | 11,745,198 |
Sector | Technology | Health |
52-Week High | $329.23 | $11.55 |
52-Week Low | $205.77 | $1.98 |
Typical Hold Time | 88 Days | 0 Days |
Enterprise Value | $264.89B | $10.79B |
Dividend Yield | 3.07% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IBM's stock trades at $220.51, down 0.35% on the day, amid a bearish technical signal. The company reported strong 2025 results with revenue of $67.54B and net income of $10.59B, beating earnings expectations in recent quarters. Analyst consensus is a Buy with a $256.69 price target, though technical indicators show resistance near $222. Recent news highlights IBM's focus on AI, including self-hosted deployment for its Bob platform.
IBM presents a mixed outlook with solid fundamentals and AI growth potential offset by near-term technical weakness and competitive pressures. The stock's valuation appears reasonable with a P/E of 19.58, but investors face risks from execution challenges and market volatility. Upside hinges on sustained earnings growth and successful AI integration.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About International Business Machines Corp
International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.
Read more on IBM →About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →
